Peptides vs TRT: Different Tools for Different Problems
Peptides are not an alternative to testosterone therapy. Testosterone replacement treats one diagnosed condition, low testosterone, with FDA-approved products and established monitoring. "Peptide" describes a molecule's chemistry, not what it does, and most peptides sold online are not FDA-approved for any use. The one peptide this page compares with testosterone is sermorelin, which acts on growth hormone, not testosterone.
If low testosterone has been confirmed, testosterone therapy, or for some men enclomiphene, is what treats it. Sermorelin answers a different question.
Sermorelin and TRT side by side
| Testosterone replacement (TRT) | Sermorelin | |
|---|---|---|
| What it is | Testosterone, the hormone itself | A GHRH analog: a peptide copy of part of the hormone that tells the pituitary to release growth hormone |
| How it works | Replaces testosterone directly | Signals the pituitary to release its own growth hormone |
| What it is used for | Diagnosed testosterone deficiency | Not a treatment for low testosterone; offered at ACT 2 around sleep, recovery and body composition after a workup |
| How it is taken at ACT 2 | Route and preparation chosen by your clinician at the visit | A dissolving tablet (ODT) |
| Diagnosis first | Two morning testosterone measurements plus symptoms | Baseline labs and a workup of the symptoms |
| What is monitored | Testosterone, hematocrit and PSA on a guideline schedule | IGF-1 and symptom review, set by your clinician |
| Regulatory status | FDA-approved testosterone products exist; dispensed as manufactured at ACT 2 | No FDA-approved sermorelin is marketed today; compounded, not FDA-approved |
| Controlled substance | Yes: labs and a live visit required | No |
| Who it tends to suit | Men with confirmed low testosterone | Adults whose sleep or recovery changes have been worked up, who accept a limited evidence base |
| Cost at ACT 2 | $249 first month, then $149 a month | $199 a month |
The distinction that matters most: a testosterone diagnosis is a testosterone problem, and no peptide is an established treatment for it. Insulin and semaglutide are peptides; so are research compounds with no human outcome data at all. The word tells you about structure, not whether something works, whether it is safe, or whether it is legal to sell.
Why "peptides" is not a treatment category
A peptide is a short chain of amino acids. That is the whole definition. The compounds sold under the label do unrelated things: some act on appetite, some on growth hormone release, some are marketed for tissue repair, and some have no established action in humans.
Some peptides are important medicines. Their approval came from trials, one compound at a time, not from being peptides. The only useful questions are what a specific compound is, what it is approved for, and what human evidence exists for the use being proposed.
The regulatory picture
Most peptides sold online are not FDA-approved for any use. Many reach buyers through "research chemical" sellers that label them "research use only" or "not for human consumption." The FDA has said in warning letters that this labeling is not a defense when the evidence shows a product is intended for people, and it has cited sellers for marketing unapproved new drugs this way. Material sold like that is not made or tested as a medicine.
The FDA has also flagged specific peptides in compounding. Its list of bulk drug substances that may present significant safety risks names a number of peptides, citing possible immune reactions, impurities, and in some cases no human exposure data. Which substances are affected has changed over time and is still changing. The red flags when buying peptides online guide covers what to look for.
Sermorelin sits in a different position. It was once sold as an FDA-approved injection, GEREF, indicated for growth hormone deficiency in children and for testing pituitary function. That product was discontinued, and the FDA determined in 2013 that it was not withdrawn for reasons of safety or effectiveness. No FDA-approved sermorelin is marketed today. What ACT 2 prescribes is compounded by a licensed pharmacy as a dissolving tablet, and it is not FDA-approved. Every meaningful clinical study of sermorelin used an injected route; there is no published human data establishing what a dissolving tablet delivers. The sermorelin ODT page is direct about that.
Testosterone has FDA-approved products and guidelines from the Endocrine Society and the American Urological Association that define who should receive it and how it is monitored. It is a controlled substance, which is why bloodwork and a live visit come before any prescription at ACT 2.
ACT 2 does not publish dosing, protocols or preparation instructions for any compound. Where you find those freely available for unapproved compounds, that is itself information about the source.
Where the goals overlap, and where they do not
The comparison usually comes up around three goals.
Low testosterone. Testosterone therapy treats it directly. Sermorelin does not, and no marketed peptide is an established treatment for testosterone deficiency. If the diagnosis is real, this is not a choice between two options. Getting the test right comes first.
Body composition. Peptides that act on growth hormone are marketed for it, and the human evidence for meaningful, lasting change in healthy adults is much thinner than the marketing suggests. Resistance training and adequate protein remain the best-supported interventions; muscle loss versus fat gain explains why.
Energy, sleep and recovery. Neither is a reliable answer on its own. Fatigue in midlife is often thyroid, iron, sleep apnea, mood, glucose handling or alcohol, and it is worth finding which before buying anything. What your tiredness pattern says is a good start; sermorelin and sleep covers what is and is not known there.
Monitoring and safety
On testosterone, the guideline schedule checks testosterone and hematocrit after starting and then periodically, with PSA, because testosterone can thicken the blood and acts on the prostate. It suppresses sperm production, so fertility plans are discussed first.
On sermorelin, IGF-1 is the usual marker of growth hormone activity, and your baseline and follow-up are the only real evidence about whether this route is doing anything for you. IGF-1 on sermorelin explains the test; sermorelin and cancer risk covers why any history of malignancy is reviewed first. Sermorelin is not offered at ACT 2 as a treatment for diagnosed adult growth hormone deficiency, which is referred to a specialist.
What each costs at ACT 2
| Treatment | Option | Price | How it is billed |
|---|---|---|---|
| Testosterone Replacement Therapy (TRT) | New patient | $249 | First month, including the new-patient evaluation |
| Refill | $149 | Each month after the first | |
| Sermorelin ODT | 1 month | $199 | Monthly |
The testosterone program is $249 for the first month, which covers the new-patient workup and the live visit, then $149 a month. Sermorelin ODT is $199 a month, which is more than the testosterone refill rate and less than the first testosterone month. That is a price comparison only. Lab work is billed separately; the TRT cost page and the sermorelin cost page set out each in full.
When neither is the answer
- When low testosterone has not been confirmed on two morning measurements. Neither is a substitute for the diagnosis.
- When a correctable cause is behind the symptoms: sleep apnea, a medication, thyroid disease, low iron or alcohol.
- When the goal is strength or body composition in a man with normal testosterone. Training, protein and sleep do more, with better evidence.
- When the offer is a peptide with no clear answer to "what is it approved for?" That is the answer.
Frequently asked questions
No. Testosterone therapy treats diagnosed testosterone deficiency directly, and no marketed peptide is an established treatment for it. Sermorelin, the peptide ACT 2 compares here, acts on growth hormone release, not testosterone. If low testosterone is confirmed on two morning measurements, testosterone therapy or, for some men, enclomiphene is what treats it. A peptide answers a different question.
A few specific peptide medicines are, such as insulin and semaglutide. Most peptides sold online are not FDA-approved for any use, and many are sold as "research use only," which the FDA has said is no defense when a product is intended for people. No FDA-approved sermorelin is marketed today; the sermorelin ACT 2 prescribes is compounded and not FDA-approved.
No. Sermorelin is a peptide that signals the pituitary to release its own growth hormone. Testosterone therapy replaces testosterone itself. They act on different hormones, are monitored with different labs and treat different problems. At ACT 2, sermorelin is a compounded dissolving tablet; testosterone is a manufactured prescription medication and a controlled substance.
They act on different hormones, so one does not rule out the other in principle. Whether combining them makes sense for you depends on what each is meant to address, what your labs show and how each would be monitored. It is a clinical decision made at your visit, not something to plan from an article, and both medications should be known to whoever manages your care.
Peptides that act on growth hormone are marketed for it, but human evidence for meaningful, lasting gains in healthy adults is thin. Resistance training and adequate protein remain the best-supported approach. In men with confirmed testosterone deficiency, testosterone therapy is the established treatment, decided with a clinician after testing.
Because ACT 2 does not publish dosing for any medication, approved or compounded. Dosing is decided for you individually after an eligibility review. Freely available dosing for unapproved compounds should be treated as a warning about the source rather than a service.
Where this fits in your plan
If low testosterone is the question, the answer is a proper diagnosis followed by an established treatment, not a compound from an adjacent category. If sleep, recovery or body composition is the question, the best-supported steps are training, protein, sleep and correcting what a panel finds, and sermorelin is a considered option only after that workup.
We measure first. Then we act.
References
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Updated April 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- U.S. Food and Drug Administration. Warning Letter: Wholesale Peptide, MARCS-CMS 729447 ("research use only" labeling; unapproved new drugs). June 17, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wholesale-peptide-729447-06172026
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration. Determination That GEREF (Sermorelin Acetate) Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register 78 FR 14095, March 4, 2013. https://www.govinfo.gov/content/pkg/FR-2013-03-04/html/2013-04827.htm
- U.S. Food and Drug Administration. Drugs@FDA: GEREF, NDA 020443 (marketing status: discontinued). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. American Urological Association, 2018, validity confirmed 2024. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Endocrine Society. Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline, 2018. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
- Back toCompare
- Men's TRT programMonitored testosterone replacement for men with diagnosed low testosterone.Read
- Sermorelin ODTThe needle-free route to sermorelin — offered honestly, including what we can't tell you about it.Read
- TRT vs enclomipheneOne replaces testosterone, the other signals your body to make more. Mechanism, fertility, monitoring, regulatory status and cost side by side.Read
- Sermorelin costSermorelin at ACT 2 costs $199 a month, medication and care included. Why it only exists compounded, and why insurance won't cover it.Read
- Peptides FAQStraight answers on peptides — what they are, whether they are legal or FDA-approved, where the evidence is only preclinical, and how to judge a provider.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Prices shown are current catalog prices and are confirmed at your eligibility review; the price comparison is a comparison of cost only, not of effectiveness.